MORAb-003, a fully humanized monoclonal antibody against the folate receptor alpha, for the potential treatment of epithelial ovarian cancer.
Morphotek Inc is developing MORAb-003, a humanized monoclonal antibody directed against folate receptor alpha, for the potential treatment of ovarian cancer. Phase II clinical trialsof MORAb-003, either alone or in combination with platinum/taxane chemotherapy, are underway in ovarian cancer patients experiencing their first disease recurrence.
T1 T2 T3 T4 T5 T6
CHEMICAL CHEMICAL CHEMICAL CHEMICAL GENE-Y GENE-Y
platinum taxane folate folate folate receptor alpha folate receptor alpha